| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Strategic Planning > Snapshot of Events on Refco Scandal |
|
E-Folder - Snapshot of Events on Refco Scandal
One of the largest corporate scandals was Refco collapse. Investigations of it According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product started in two months after it had happened. The main person that made this c ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ollapse possible, Bernett, was arrested for giving false information to the in lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. vestors, commerce between states. Trading of Refco shared stopped soon after t here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe hat despite the fact that Bernett’s lawyers assured public that company was g d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ing to fight. The crash of Refco happened after prices per share went extremel ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc y low and it was totally destroyed. Soon after these events with help of fede easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ral bankruptcy court Refco stated its wiliness to stay in business. At that ti nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically me Refco declared that it had about $50 billion what would be the fourth bigge and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ st bankruptcy in economics of the USA if they’d loose everything. But the comp ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ny had declared that they had only $16 billion in assets and $16 more billion ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a in liabilities. Refco group had much more steps to take and when they were abo dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ut to fulfill all of them the judge who was in charge of this process has deci cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ded that all this business has to be sold to Main Financial what happened a mo tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nth later. The problem of Refco was that it ahs never had a clean reputation t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel n society and even though the losses of the shareholders were significantly no ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t so big it still was a huge scandal. It has to be added that it seems that ne y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ither company auditor nor the companies-satellites have known anything about c . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de orporation’s hidden debt. The company has never publicly admitted that these a elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ctions were planned. It has spent about $5 million to settle down the conflict tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How The Humble Telephone Will Build Your Business Organization Performance - Effort vs Results Email and the Internet: The Corporate Double-Edged Sword
|